News

Thu 07 Dec 2023

Appointment of Dr Eckhard von Keutz as Scientific Advisor

Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor

Wed 29 Nov 2023

Kantify will use its AI platform to tackle 5 rare diseases

Kantify is selected by the European Commission to perform an unprecedented research project on rare diseases and AI

Thu 05 Oct 2023

Kantify speaking at Slush'D Leuven

Kantify will be speaking in the panel on "AI: redefining business or enhancing roles"

Tue 19 Sep 2023

TV debate on the impact of AI on human thought

Kantify was invited to discuss about AI's impact on human thought

Thu 24 Aug 2023

Kantify speaking at the 6th TPD Summit in Boston

Join Kantify's Session at the 6th TPD Summit: Unveiling the Power of AI in Protein Degradation

Thu 15 Jun 2023

Presentation at Cafes de L'Innovation

Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet

Mon 12 Jun 2023

Event: How AI is changing the game in drug discovery

Kantify is presenting its work on AI based drug discovery at an event where Insilico Medicine, Microsoft, and others will also be present

Tue 06 Jun 2023

Kantify Nominated as Early Startup to Watch by Sifted

We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report

Mon 22 May 2023

Pitch and Meet at the Tech.eu Summit

Kantify has been selecting to pitch at the Tech.eu Summit 2023 and will present Sapian, its solution for AI powered small molecule discovery

Fri 12 May 2023

EIT Health Gold Track Workshop Invitation

Kantify is invited to participate in the first stage of the selective EIT Health Gold Track Workshop for biotech and medtech companies

Tue 21 Mar 2023

Kantify nominated as Deep Tech company of the year

Kantify has been nominated as one of the most innovative Deep Tech companies of Belgium for the 2023 Data News Awards

Fri 10 Mar 2023

Portrait in BECI Magazine, Brussels Business

In the March Edition of Brussels Business, a 2 page portrait is dedicated to our CEO and our team